NHI.no
Annonse
Informasjon, tilstand

Blodpropp i ben eller arm, dyp venetrombose (DVT)

Blodpropp i vener rammer hvert år omtrent to av 1000 mennesker over 50 år. Det kan gi varierende grad av plager, men typisk er at det syke benet blir ømt, hovent og varmt.

Mange forhold kan føre til dannelse av blodpropp i de dype venene. En særlig viktig faktor er manglende bevegelse, for eksempel langvarig sengeleie ved sykdom, etter en operasjon eller langvarig stillesitting i forbindelse med lange reiser.

Sist oppdatert:

19. okt. 2022

Vil du vite mer

Vil du vite mer - Undervisningsprogram

Dette dokumentet er basert på det profesjonelle dokumentet Dyp venetrombose . Referanselisten for dette dokumentet vises nedenfor

  1. Kakkos SK, Gohel M, Baekgaard N, et al. European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. Eur J Vasc Endovasc Surg 2021; 61: 9-82. pmid:33334670 PubMed
  2. Hansson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. Arch Intern Med 1997; 157: 1665-70. PubMed
  3. Silverstein MD et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year poplulation-based study. Arch Intern Med 1998; 158: 585-93. PubMed
  4. Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365: 1163-74. PubMed
  5. Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008; 28: 360-2. PMID: 18296591 PubMed
  6. Bell EJ, Lutsey PL, Basu S, et al. Lifetime risk of venous thromboembolism in two cohort studies. Am J Med 2016;129:339.e19-26. PMID: 26597668 PubMed
  7. Apenteng PN, Hobbs FR, Roalfe A, et al. Incidence of venous thromboembolism in care homes: a prospective cohort study. Br J Gen Pract 2017 Feb; 67 (655): e130-e137. pmid:28093420 PubMed
  8. Meaidi A, Mascolo A, Sessa M, et al. Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study. BMJ. 2023; 382: e074450. PMID: 37673431 PubMed
  9. Goel R, Patel EU, Cushing MM, et al. Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry. JAMA Surg 2018; 153: 826-33. pmid:29898202 PubMed
  10. la Roi-Teeuw HM, van Smeden M, Bos B, et al. Estimated causal effects of common respiratory infections on cardiovascular risk: a meta-analysis. Open Heart 2023. pmid:38016788 PubMed
  11. Chang S-L, Huang Y-L, Lee M-C, et al. Association of Varicose Veins With Incident Venous Thromboembolism and Peripheral Artery Disease. JAMA 2018; 319: 807-17. pmid: 29486040 PubMed
  12. Walker RF, Zakai NA, MacLehose RF, et al. Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism. JAMA Intern Med 2019. pmid:31710339 PubMed
  13. Trigg DE, Wood MG, Koides PA et al.Hormonal Influences on Haemostasis in Women. Sem Thromb Haemost 2011; 37: 77-86 PubMed
  14. Canonico M, Plu-Bureau G, Lowe GDO, Scarabin P-Y. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 2008; 336: 1227-31. British Medical Journal
  15. Rodina MT, Pendleton R, Wheeler M, Rodgers GM. The treatment of venous thromboembolism in special populations Thrombosis Research 2007; 119: 391-402. PubMed
  16. Laliberté F, Dea K, Duh MS, et al. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy. Menopause 2011; 18: 1052-9. PubMed
  17. Pollak, AW, McBane, RD. Succinct review of the new VTE prevention and management guidelines. Mayo Clinic Proceedings 2014; 89, 3; 394-408
  18. Wells PS, Anderson D, Rodger M et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Eng J med 2003; 349: 1227-35. New England Journal of Medicine
  19. Bounemeaux H, Perrier A and Righini M. Diagnosis of venous thromboembolism: un update. Vasc Med 2010; 15: 399-406. PubMed
  20. Silveira PC, Ip IK, Goldhaber SZ, et al. Performance of Wells score for deep vein thrombosis in the inpatient setting. JAMA Intern Med 2015; 175: 1112-7. DOI: 10.1001/jamainternmed.2015.1687 DOI
  21. Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 2014; 311: 1117-24. pmid:24643601 PubMed
  22. Kearon C , et al. A randomized trial of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis: D-dimer testing compared with repeated ultrasonography. Ann Intern Med 2005; 142: 490-6. Annals of Internal Medicine
  23. Huo MH and Spyropoulis AC. The eighth American college of chest phycisians guidelines on venous thromboembolism prevention: implications for hospital prophylaxis strategies. J Thromb Thrombolysis 2010 (e-pub ahead of print).
  24. Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post-thrombotic syndrome: a randomized placebo-controlled trial. Lancet 2013; doi:10/1016/S0140-6736(13)61902-9
  25. Berntsen CF, Kristiansen A, Akl EA, et al. Compression stockings for preventing the postthrombotic syndrome in patients with deep vein thrombosis. Am J Med. 2016. PMID: 26747198 PubMed
  26. Streiff MB, Agnelli G, Connors JM, et al. Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis 2016; 41: 32-67. pmid:26780738 PubMed
  27. Wells PS, Forgie MA, Rodger MA. Treatment of venous thromboembolism. JAMA 2014; 311:717-28. doi: 10.1001/jama.2014.65 DOI
  28. Vandvik PO. Norsk Selskap for Trombose og Hemostase. Retningslinjer for antitrombotisk behandling og profylakse - 2020 cms.legehandboka.no
  29. Wang X, Ma Y, Hui X, et al. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis. Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD010956. doi: 10.1002/14651858.CD010956.pub3 DOI
  30. Dawwas GK, Leonard CE, Lewis JD, Cuker A. Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban: An Analysis of Real-World Data. Ann Intern Med 2022; 175: 20-28. pmid:34871048 PubMed
  31. Dahm AEA. Cancer and Thrombosis: New Treatments, New Challenges. Med Sci (Basel) 2021; 9: 41. pmid:34204957 PubMed
  32. Lyman GH, Carrier M, Ay C, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 2021; 5: 927-74. pmid:33570602 PubMed
  33. Schrag D, Uno H, Rosovsky R, et al. Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer A Randomized Clinical Trial. JAMA 2023. pmid:37266947 PubMed
  34. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J 2020; 41: 543-603. doi:10.1093/eurheartj/ehz405 DOI
  35. Goldenberg NA, Kittelson JM, Abshire TC, et al. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism The Kids-DOTT Randomized Clinical Trial. JAMA 2022; 327: 129-37. pmid:35015038 PubMed
  36. Khan F, Tritschler T, Kimpton M, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism A Systematic Review and Meta-analysis. Ann Intern Med 2021. pmid:34516270 PubMed
  37. Meng J, Liu W, Xiao Y, et al. Is it necessary to wear compression stockings and how long should they be worn for preventing post thrombotic syndrome? A meta-analysis of randomized controlled trials. Thromb Res 2023; 225: 79-86. pmid:37030189 PubMed
  38. Alexander M, et al. Risk-directed ambulatory thromboprophylaxis in lung and gastrointestinal cancers: The TARGET-TP randomized clinical trial. JAMA Oncol 2023; 9: 1536. pmid:37733336 PubMed
  39. Simes J, Becattini C, Agnelli G, et al. Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration. Circulation. 2014 Sep 23;130(13):1062-71 PubMed
  40. Beccatini C, Agnelli G, Schenone A, et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012; 366: 1959-67. New England Journal of Medicine
  41. Brighton TA, Eikelbooom JW, Mann K, et al. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012. doi:10.1056/NEJMoa1210384 DOI
  42. Weitz JI, Lensing AW, Prins MH, et al. Rivaroxaban or aspirin for extended treatment of venous thromboembolism. N Engl J Med 2017. pmid:28316279 PubMed
  43. Gavish I, Brenner B. Air travel and the risk of thromboembolism. Intern Emerg Med. 2010 Nov 6. Epub ahead of print.
  44. Watson HG and Baglin TP. Guidelines on travel-related venous thrombosis. Br J Haematol 2011; 152: 31-34. PMID: 21083651 PubMed
  45. Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012; 141: 7S-47S. PubMed
  46. Sachdeva A, Dalton M, Lees T. Graduated compression stockings for prevention of deep vein thrombosis. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No.: CD001484. DOI: 10.1002/14651858.CD001484.pub4. Accessed 13 July 2023. The Cochrane Library
  47. ICM-VTE Hip & Knee Delegates. Recommendations from the ICM-VTE: Hip & Knee. J Bone Joint Surg Am 2022; 104: 180-231. pmid:35315610 PubMed
  48. Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med 2018; 378: 699-707. doi:10.1056/NEJMoa1712746 DOI
  49. Carrier M, Le Gal G, Wells PS et al. Systematic review: case-fatality rates of recurrent Venous Thromboembolism and major Bleeding Events Among Patients treated for venous Thromboembolism. Ann Intern Med 2010; 152: 578-589. PubMed
  50. Jørgensen CT, Tavoly M, Førsund E, et al. Incidence of bleeding and recurrence in isolated distal deep vein thrombosis: findings from the Venous Thrombosis Registry in Østfold Hospital. J Thromb Haemost 2023; 21: 2824-2832. pmid:37394122 PubMed
  51. Garry J, Duke A, Labropoulos N. Systematic review of the complications following isolated calf deep vein thrombosis. Br J Surg 2016; 103: 789-96. pmid:27060255 PubMed
  52. Khan F, Rahman A, Carrier M, et al. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis. BMJ 2019; 366: l4363. pmid:31340984 PubMed
  53. Husseinzadeh H, Carrier M. Occult cancer detection in patients with hemostatic disorder and venous thromboembolism. Thromb Res 2017. pmid:28587726 PubMed
  54. Carrier M, Lazo-Langner A, Shivakumar S, et al. Screening for occult cancer in unprovoked venous thromboembolism. N Engl J Med. 2015. PMID: 26095467 PubMed
  55. Semb VB, Tveit A. Begrenset malignitetsutredning ved idiopatisk venøs trombose. Tidsskr Nor Legeforen 2014; 134: 407-11. doi:10.4045/tidsskr.13.0310 DOI
  56. Eerenberg ES, Middeldorp S, Levi M, et al. Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists. J Thromb Haemostat 2015; 13: 1590-6. pmid:26179293 PubMed
  57. Amin EE, Bistervels IM, Meijer K, et al. Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis. Blood 2018. pmid:30237155 PubMed
Annonse
Annonse